Invention Grant
US09539240B2 Drug combinations and methods for reducing or maintaining cholesterol or HDL/LDL levels
有权
用于降低或维持胆固醇或HDL / LDL水平的药物组合和方法
- Patent Title: Drug combinations and methods for reducing or maintaining cholesterol or HDL/LDL levels
- Patent Title (中): 用于降低或维持胆固醇或HDL / LDL水平的药物组合和方法
-
Application No.: US14061880Application Date: 2013-10-24
-
Publication No.: US09539240B2Publication Date: 2017-01-10
- Inventor: John Brew , Robin Mark Bannister
- Applicant: Biocopea Limited
- Applicant Address: GB London
- Assignee: BIOCOPEA LIMITED
- Current Assignee: BIOCOPEA LIMITED
- Current Assignee Address: GB London
- Agency: One3 IP Management, P.C.
- Agent Dean G. Stathakis; Peter D. Weinstein
- Main IPC: A61K31/351
- IPC: A61K31/351 ; A61K31/40 ; A61K31/22 ; A61K31/405 ; A61K31/192 ; A61K45/06 ; A61K31/19 ; A61K31/202 ; A61K31/216 ; A61K31/366 ; A61K31/4406 ; A61K31/4418 ; A61K31/47 ; A61K31/505
Abstract:
The present specification discloses compositions comprising a pharmaceutical composition to reduce or maintain LDL and/or cholesterol levels in an individual and a plurality of therapeutic compounds to increase or maintain HDL levels in an individual. The present specification also discloses a treatment protocol wherein a pharmaceutical composition is administered to an individual on a schedule wherein the pharmaceutical composition is provided for a period of time and then not provided to the individual and this treatment protocol is repeated for the term of the individual's treatment.
Public/Granted literature
- US20140113948A1 Drug Combinations and Uses Public/Granted day:2014-04-24
Information query
